tirzepatide site reaction Injection Treatment: Evidence-Based Management Guide tirzepatide redness at injection site

& Seufert, J

Nov 2009;32 Suppl 2:S157-163

According to the UK SmPC, the most common side effects include: Nausea (1222% of patients, dose-dependent) Diarrhoea (1216%) Vomiting (610%) Decreased appetite (59%) Constipation (67%) These effects are typically mild to moderate, occurring predominantly during dose escalation, and diminish over 48 weeks

Summary: B12 injections begin working at a cellular level immediately, though noticeable symptom improvement typically occurs within 4872 hours to several weeks depending on deficiency severity

Thus, for cardiologists and internists considering Wegovy primarily for CV risk reduction, careful titration, monitoring, and collaboration with endocrinology/obesity medicine can help balance tolerability with longterm adherence

Serious risks like pancreatitis, gallbladder disease, and thyroid concerns require monitoring